Therapy program modification

Patent metadata

Field	Value
Publication number	US-8958870-B2
Application number	US-98974009-A
Country	US
Kind code	B2
Filing date	Jan 23, 2009
Priority date	Apr 29, 2008
Publication date	Feb 17, 2015
Grant date	Feb 17, 2015

Abstract

A therapy program may be modified based on information indicative of a change in a therapy field, which may represent a region of a patient's tissue to which therapy is delivered. Upon receiving information indicative of a therapy field change, an algorithmic model of a present therapy field may be generated and compared to an algorithmic model of a baseline therapy field, which indicates a therapy field that provides efficacious therapy to the patient. If a characteristic of the present therapy field differs from the baseline therapy field model, the current therapy program may be modified. In another example, upon receiving information indicative of a therapy field change, the current therapy program may be modified, and an algorithmic model of a therapy field based on the modified therapy program may be compared to a baseline therapy field model to determine whether the modified therapy program is a suitable alternative.

First claim

The invention claimed is:

1. A method comprising:
receiving, with one or more processors, information indicative of a change in a first therapy field, wherein the first therapy field was generated by prior delivery of therapy, by a medical device, to tissue of a patient according to a therapy program, wherein prior to the change in the first therapy field, when the medical device delivers therapy according to the therapy program, the first therapy field is generated, and wherein the change in the first therapy field occurs without change to the therapy program;
in response to receiving the information indicative of the change in the first therapy field, generating, with the one or more processors, a first therapy field model based on the therapy program that is used to generate the first therapy field prior to the change in the first therapy field and the information indicative of the change in the first therapy field;
comparing, with the one or more processors, the first therapy field model to an algorithmic model of a baseline therapy field; and
modifying, with the one or more processors, the therapy program based on the comparison of the first therapy field model to the algorithmic model of the baseline therapy field.

2. The method of claim 1 , wherein the therapy is delivered to the patient, by the medical device, via a plurality of electrodes, and receiving the information indicative of the change in the first therapy field comprises detecting an impedance change of at least one electrode of the plurality of electrodes.

3. The method of claim 2 , wherein generating the first therapy field model comprises generating the first therapy field model based on the therapy program and the impedance change of the at least one electrode.

4. The method of claim 1 , wherein the therapy is delivered to the patient, by the medical device, via a plurality of electrodes, and receiving the information indicative of the change in the first therapy field comprises detecting an open circuit condition of at least one electrode of the plurality of electrodes.

5. The method of claim 1 , wherein the therapy is delivered to the patient, by the medical device, via a plurality of electrodes, and receiving the information indicative of the change in the first therapy field comprises detecting movement of at least one electrode of the plurality of electrodes relative to a target tissue site within the patient.

6. The method of claim 1 , wherein receiving the information indicative of the change in the first therapy field comprises detecting a change in a hardware characteristic of the medical device.

7. The method of claim 1 , wherein generating the first therapy field model based on the therapy program and the information indicative of the change in the first therapy field comprises:
receiving patient anatomy data; and
entering the patient anatomy data and the information indicative of the change in the first therapy field into an electrical field model equation that defines how an electrical field will propagate through the tissue from an implant system comprising the medical device delivering the therapy according to the first therapy program.

8. The method of claim 1 , wherein comparing the first therapy field model to the algorithmic model of the baseline therapy field comprises comparing at least one field characteristic of the first therapy field model and the algorithmic model of the baseline therapy field.

9. The method of claim 8 , wherein the field characteristic comprises at least one of stimulation volume, a centroid of stimulation, activated neurons, an amplitude of the voltage or current at a spatial point within the stimulation volume or a charge density.

10. The method of claim 1 , wherein modifying the therapy program comprises modifying the therapy program to substantially maintain at least one field characteristic of the baseline therapy field.

11. The method of claim 1 , wherein modifying the therapy program results in a modified therapy program, the method further comprising determining an efficacy of the modified therapy program.

12. The method of claim 1 , further comprising generating the algorithmic model of the baseline therapy field, wherein generating the algorithmic model of the baseline therapy field comprises:
receiving patient anatomy data that describes at least one characteristic of the tissue of the patient proximate to a therapy delivery element implanted within the patient and coupled to the medical device;
receiving user input indicating at least one of a configuration or a location of the therapy delivery element;
receiving user input indicating at least one therapy parameter value for therapy delivery via the therapy delivery element; and
generating the algorithmic model of the baseline therapy field that represents where at least one of electrical stimulation or therapeutic agent delivery will propagate from the therapy delivery element based on the patient anatomy data, the configuration of the at least one therapy delivery element, and the at least one therapy parameter value.

13. The method of claim 1 , further comprising generating the algorithmic model of the baseline therapy field, wherein generating the algorithmic model of the baseline therapy field comprises generating the algorithmic model of at least one of an electrical field, an activation field, a voltage gradient or a current density that provides efficacious therapy to the patient.

14. The method of claim 1 , wherein the baseline therapy field comprises a known therapy field that results from delivery of stimulation according to at least one therapy program determined to deliver efficacious therapy.

15. The method of claim 1 , further comprising:
controlling the medical device to deliver therapy according to the modified therapy program.

16. A system comprising:
an implantable medical device configured to deliver therapy to tissue of a patient according to a therapy program, wherein when the implantable medical device delivers therapy according to the therapy program a first therapy field is generated within the tissue; and
a processor configured to:
receive information indicative of a change in the first therapy field after the generation of the first therapy field within the tissue via the delivery of the therapy, by the implantable medical device, to the tissue of the patient according to the therapy program, wherein the change in the first therapy field occurs without change to the therapy program,
in response to reception of the information indicative of the change in the first therapy field, generate a first therapy field model based on the therapy program that is used to generate the first therapy field prior to the change in the first therapy field and the information indicative of the change in the first therapy field,
compare the first therapy field model to an algorithmic model of a baseline therapy field, and
modify the therapy program based on the comparison of the first therapy field model to the algorithmic model of the baseline therapy field.

17. The system of claim 16 , further comprising a medical device programmer configured to communicate with the implantable medical device, wherein the medical device programmer comprises the processor.

18. The system of claim 16 , further comprising a memory configured to store at least one of the algorithmic model of the baseline therapy field, hardware characteristics of the implantable medical device, hardware characteristics of a therapy delivery element coupled to the implantable medical device or patien

Assignees

• Gerber Martin T
• Rondoni John C
• Medtronic Inc

Inventors

• Gerber Martin T
• Rondoni John C

Classifications

• A61N1/37247

  User interfaces, e.g. input or presentation means · CPC title

• A61N1/36071

  Pain · CPC title

• A61N1/37 Primary

  Monitoring; Protecting · CPC title